The Latest Breaking News from Jason Snipe

Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades” on Tuesday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he is staying long on AbbVie Inc. (NYSE:ABBV).

Benzinga · Oct 22, 2025

ServiceNow, Vertex Pharmaceuticals And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” on Thursday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he likes ServiceNow, Inc. (NYSE:NOW), which is down 14% year-to-date.

Benzinga · Oct 3, 2025

AMD, Taiwan Semiconductor And A Financial Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Odyssey Capital Advisors’ Chief Investment Officer Jason Snipe said he likes Advanced Micro Devices, Inc. (NASDAQ:AMD). NVIDIA Corporation (NASDAQ:NVDA), he says, is not the only game in town.

Benzinga · Jun 26, 2025

CNBC's Final Trades: Nvidia, Amazon, Wynn Resorts And This Dividend Play

On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Amplify CWP Enhanced Dividend Income ETF (NYSE: DIVO) is “another high-quality dividend cover cal

Benzinga · Mar 25, 2022

Why This Investor Bought Bank of America Stock

The financials have come under significant pressure amid impending rate hikes and increasing geopolitical tensions. With Bank Of America Corp (NYSE: BAC) shares down more than 15% over the last month, Odyssey Capital's Jason Snipe decided to buy in.

Benzinga · Mar 4, 2022